GlassScriptPhysician profile
Kelli M Carver
NPI 1245558923
$4,354.66
in general payments reported to CMS, 2019-2025
37 companies · $881 in 2025
The $881 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $860 · 2022: $930 · 2023: $1,004 · 2024: $679 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,564.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $689.00 | 2021-2025 | |
| Novo Nordisk INC | $454.33 | 2021-2025 | Wegovy, Ozempic, Saxenda |
| Astrazeneca Pharmaceuticals LP | $405.95 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $374.92 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $359.60 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $233.96 | 2021-2025 | Jardiance, Ofev |
| Exact Sciences Corporation | $231.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $169.40 | 2021-2022 | |
| Amgen INC. | $166.56 | 2022-2025 | Repatha, Otezla, Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $144.41 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $101.02 | 2023-2025 | Libtayo |
| Lilly USA, LLC | $95.54 | 2021-2024 | Zepbound, Jardiance |
| Kowa Pharmaceuticals America, INC. | $87.40 | 2021-2023 | Livalo, Seglentis |
| Janssen Pharmaceuticals, INC | $80.67 | 2023-2024 | Spravato |
| Vertex Pharmaceuticals Incorporated | $62.99 | 2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Carver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.